Pfizer COVID drug reduces death risk in high-risk adults by 89%

Pfizer Inc. unveiled on Tuesday that its coronavirus oral drug Paxlovid reduces the risk of death and hospitalization for high-risk adults by 89% and 88% if the treatment is respectively taken within …